Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.

OBJECTIVE To evaluate the role of non-HDL cholesterol and apolipoprotein (apo)B, markers of all potentially atherogenic lipoproteins, as predictors of cardiovascular disease (CVD) in comparison with LDL cholesterol in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS We prospectively followed 746 diabetic men in the Health Professionals' Follow-up Study who were aged 46-81 years and free of CVD or cancer at the time of blood draw in 1993-1994. During 6 years of follow-up, we ascertained 103 incident CVD cases. RESULTS We used Cox proportional hazard modeling to estimate the relative risk (RR) of CVD. After adjustment for age, BMI, and other lifestyle risk factors, the multivariate RR of CVD (the highest versus the lowest quartile) was 2.34 (95% CI 1.26-4.32) for non-HDL cholesterol, 2.31 (1.23-4.35) for apoB, and 1.74 (0.99-3.06) for LDL cholesterol. Comparisons of nested models indicate that non-HDL cholesterol, but not apoB, adds significantly to the prediction of CVD risk beyond LDL cholesterol. The area under the receiver operating characteristic curve was 0.685, 0.691, 0.695, and 0.722 for the CVD risk-prediction model with LDL cholesterol, apoB, non-HDL cholesterol, and total cholesterol-to-HDL cholesterol ratio (or the non-HDL-to-HDL cholesterol ratio), respectively. CONCLUSIONS Non-HDL cholesterol and apoB are more potent predictors of CVD incidence among diabetic men than LDL cholesterol. Statistically, the ratio of total to HDL cholesterol is the best predictor of CVD in this cohort of diabetic men.

[1]  S. Grundy,et al.  Management of Dyslipidemia in NIDDM , 1990, Diabetes Care.

[2]  K. Jablonski,et al.  Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. , 2003, Diabetes care.

[3]  M. Laakso,et al.  Dyslipidemia and Hyperglycemia Predict Coronary Heart Disease Events in Middle-Aged Patients With NIDDM , 1997, Diabetes.

[4]  M. Stampfer,et al.  Test of the National Death Index and Equifax Nationwide Death Search. , 1994, American journal of epidemiology.

[5]  P Langenberg,et al.  Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. , 2001, Archives of internal medicine.

[6]  P. Wilson,et al.  Efficacy of lipid profiles in prediction of coronary disease. , 1992, American heart journal.

[7]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[8]  M. Hong,et al.  Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. , 1991, The American journal of cardiology.

[9]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[10]  S. Grundy,et al.  Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100. , 1993, Atherosclerosis.

[11]  A. Sniderman.  Counterpoint: to (measure apo) B or not to (measure apo) B: a critique of modern medical decision-making. , 1997, Clinical chemistry.

[12]  G A Colditz,et al.  Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. , 2001, Archives of internal medicine.

[13]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[14]  Bruce Kinosian,et al.  Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios , 1994, Annals of Internal Medicine.

[15]  S. Hsia.  Non-HDL cholesterol: into the spotlight. , 2003, Diabetes care.

[16]  B. Golomb,et al.  Epidemiologic aspects of lipid abnormalities. , 1998, The American journal of medicine.

[17]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[18]  W. Willett,et al.  Cigarette smoking, relative weight, and menopause. , 1983, American journal of epidemiology.

[19]  B Kinosian,et al.  Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[20]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, East African medical journal.

[21]  E. Rimm,et al.  Prospective study of alcohol consumption and risk of coronary disease in men , 1991, The Lancet.

[22]  S. Grundy.  Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. , 2002, Circulation.

[23]  F. D. Weinfeld,et al.  The National Survey of Stroke. Clinical findings. , 1981, Stroke.

[24]  Alan C. Wilson,et al.  Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). , 1996, Circulation.